These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27177984)

  • 1. Clinical and genetic analysis of two Chinese infants with Mabry syndrome.
    Xue J; Li H; Zhang Y; Yang Z
    Brain Dev; 2016 Oct; 38(9):807-18. PubMed ID: 27177984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineation of PIGV mutation spectrum and associated phenotypes in hyperphosphatasia with mental retardation syndrome.
    Horn D; Wieczorek D; Metcalfe K; Barić I; Paležac L; Cuk M; Petković Ramadža D; Krüger U; Demuth S; Heinritz W; Linden T; Koenig J; Robinson PN; Krawitz P
    Eur J Hum Genet; 2014 Jun; 22(6):762-7. PubMed ID: 24129430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the PIGW gene associated with hyperphosphatasia and mental retardation syndrome: a case report.
    Fu L; Liu Y; Chen Y; Yuan Y; Wei W
    BMC Pediatr; 2019 Feb; 19(1):68. PubMed ID: 30813920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in PIGL in a patient with Mabry syndrome.
    Fujiwara I; Murakami Y; Niihori T; Kanno J; Hakoda A; Sakamoto O; Okamoto N; Funayama R; Nagashima T; Nakayama K; Kinoshita T; Kure S; Matsubara Y; Aoki Y
    Am J Med Genet A; 2015 Apr; 167A(4):777-85. PubMed ID: 25706356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIGO mutations in intractable epilepsy and severe developmental delay with mild elevation of alkaline phosphatase levels.
    Nakamura K; Osaka H; Murakami Y; Anzai R; Nishiyama K; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Kinoshita T; Matsumoto N; Saitsu H
    Epilepsia; 2014 Feb; 55(2):e13-7. PubMed ID: 24417746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperphosphatasia-mental retardation syndrome due to PIGV mutations: expanded clinical spectrum.
    Horn D; Krawitz P; Mannhardt A; Korenke GC; Meinecke P
    Am J Med Genet A; 2011 Aug; 155A(8):1917-22. PubMed ID: 21739589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the phenotypic spectrum of Mabry Syndrome with novel PIGO gene variants associated with hyperphosphatasia, intractable epilepsy, and complex gastrointestinal and urogenital malformations.
    Holtz AM; Harrington AW; McNamara ER; Kielian A; Soul JS; Martinez-Ojeda M; Levy PT
    Eur J Med Genet; 2020 Apr; 63(4):103802. PubMed ID: 31698102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mabry Syndrome in a Child of South Asian Descent.
    Sohail AH; Durrani MYK; Ibrahim SH; Humayun KN
    J Coll Physicians Surg Pak; 2018 Sep; 28(9):S192-S194. PubMed ID: 30173695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A post glycosylphosphatidylinositol (GPI) attachment to proteins, type 2 (PGAP2) variant identified in Mabry syndrome index cases: Molecular genetics of the prototypical inherited GPI disorder.
    Thompson MD; Knaus AA; Barshop BA; Caliebe A; Muhle H; Nguyen TTM; Baratang NV; Kinoshita T; Percy ME; Campeau PM; Murakami Y; Cole DE; Krawitz PM; Mabry CC
    Eur J Med Genet; 2020 Apr; 63(4):103822. PubMed ID: 31805394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare Genetic Developmental Disabilities: Mabry Syndrome (MIM 239300) Index Cases and Glycophosphatidylinositol (GPI) Disorders.
    Thompson MD; Knaus A
    Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PGAP3-related hyperphosphatasia with mental retardation syndrome: Report of 10 new patients and a homozygous founder mutation.
    Abdel-Hamid MS; Issa MY; Otaify GA; Abdel-Ghafar SF; Elbendary HM; Zaki MS
    Clin Genet; 2018 Jan; 93(1):84-91. PubMed ID: 28390064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurogenetic Aspects of Hyperphosphatasia in Mabry Syndrome.
    Cole DE; Thompson MD
    Subcell Biochem; 2015; 76():343-61. PubMed ID: 26219719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital diaphragmatic hernia and early lethality in PIGL-related disorder.
    Winter-Paquette LM; Al Suwaidi HH; Sajjad Y; Bricker L
    Eur J Med Genet; 2022 May; 65(5):104501. PubMed ID: 35378319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineating the phenotypic spectrum of hyperphosphatasia with mental retardation syndrome 4 in 14 patients of Middle-Eastern origin.
    Balobaid A; Ben-Omran T; Ramzan K; Altassan R; Almureikhi M; Musa S; Al-Hashmi N; Al-Owain M; Al-Zaidan H; Al-Hassnan Z; Imtiaz F; Al-Sayed M
    Am J Med Genet A; 2018 Dec; 176(12):2850-2857. PubMed ID: 30345601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal presentation of Mabry syndrome with congenital diaphragmatic hernia and phenotypic overlap with Fryns syndrome.
    Reynolds KK; Juusola J; Rice GM; Giampietro PF
    Am J Med Genet A; 2017 Oct; 173(10):2776-2781. PubMed ID: 28817240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation.
    Krawitz PM; Murakami Y; Hecht J; Krüger U; Holder SE; Mortier GR; Delle Chiaie B; De Baere E; Thompson MD; Roscioli T; Kielbasa S; Kinoshita T; Mundlos S; Robinson PN; Horn D
    Am J Hum Genet; 2012 Jul; 91(1):146-51. PubMed ID: 22683086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic variability in hyperphosphatasia with seizures and neurologic deficit (Mabry syndrome).
    Thompson MD; Roscioli T; Marcelis C; Nezarati MM; Stolte-Dijkstra I; Sharom FJ; Lu P; Phillips JA; Sweeney E; Robinson PN; Krawitz P; Yntema HG; Andrade DM; Brunner HG; Cole DE
    Am J Med Genet A; 2012 Mar; 158A(3):553-8. PubMed ID: 22315194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PGAP2 mutations, affecting the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation syndrome.
    Krawitz PM; Murakami Y; Rieß A; Hietala M; Krüger U; Zhu N; Kinoshita T; Mundlos S; Hecht J; Robinson PN; Horn D
    Am J Hum Genet; 2013 Apr; 92(4):584-9. PubMed ID: 23561847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in PGAP3 impair GPI-anchor maturation, causing a subtype of hyperphosphatasia with mental retardation.
    Howard MF; Murakami Y; Pagnamenta AT; Daumer-Haas C; Fischer B; Hecht J; Keays DA; Knight SJ; Kölsch U; Krüger U; Leiz S; Maeda Y; Mitchell D; Mundlos S; Phillips JA; Robinson PN; Kini U; Taylor JC; Horn D; Kinoshita T; Krawitz PM
    Am J Hum Genet; 2014 Feb; 94(2):278-87. PubMed ID: 24439110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperphosphatasia with mental retardation syndrome type 4 In two siblings-expanding the phenotypic and mutational spectrum.
    Akgün Doğan Ö; Demir GÜ; Kosukcu C; Taskiran EZ; Simsek-Kiper PÖ; Utine GE; Alikaşifoğlu M; Boduroğlu K
    Eur J Med Genet; 2019 Jun; 62(6):103535. PubMed ID: 30217754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.